ClinicalTrials.gg
Status unknownNCT03323047Updated Feb 18, 2021

Perioperative Tonsillectomy Protocol Development

A Phase 4 interventional study of Acetaminophen and Low-dose Dexamethasone in Tonsillitis, sponsored by London Health Sciences Centre. Status unknown at 1 site in Canada. Open to participants aged 3 Years to 13 Years. Per ClinicalTrials.gov, last updated 2021-02-18.

Sponsored by London Health Sciences Centre · Phase 4, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Feb 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
3 Years to 13 Years
Sex
All
01

Study summary

Pediatric patients who are undergoing a tonsillectomy at the Children's hospital will be randomly assigned to one of three drug groups: 1) acetaminophen (Tylenol) administered pre-operatively and a low dose of anti-inflammatory drug (dexamethasone) administered intra-operatively; 2) acetaminophen (Tylenol) administered pre-operatively and a high dose of anti-inflammatory drug (dexamethasone) administered intra-operatively; 3) no acetaminophen (Tylenol) administered pre-operatively, low dose anti-inflammatory (dexamethasone) administered intra-operatively. The present study will evaluate differences in pain management and surgical complications across the three groups of drug regimens. Main study outcomes include: pain medication administration during surgery, use of pain killers at 1-week post-operation, subjective pain scores administered in the post-anesthesia care unit (PACU) and 1 week postoperation, fluid and food intake, and complication rates (i.e. postoperative bleed rate). The hypothesis is that pain will be lowest in the group that received Tylenol and high-dose dexamethasone (Group 2).

Read the detailed description

This study will be conducted as a prospective, randomized, longitudinal, double-blinded trial at a single ambulatory surgery centre with 3 groups of 20 children. Group 1 will receive oral acetaminophen (15 mg/kg) 1 hour pre-operatively and high-dose intravenous dexamethasone (0.5 mg/kg, max. dose 10 mg) immediately after induction of anesthesia. Group 2 will receive oral acetaminophen elixir (15 mg/kg) 1 hour pre-operatively and low-dose intravenous dexamethasone (0.15 mg/kg, maximum of 8 mg) immediately after induction of anesthesia. Group 3 will receive an oral placebo 1 hour pre-operatively and low dose intravenous dexamethasone (0.15 mg/kg, maximum of 8 mg) immediately after induction of anesthesia. Dose of dexamethasone is a potential confounder if patients in the low-dose dexamethasone groups weigh enough to obtain the maximum dose (8 mg). We expect this occurrence to be rare, as dexamethasone will be dosed for ideal bodyweight, but subgroup analysis by actual dose received will be performed to compare the two dosing regimens (0.15mg/kg and 0.5 mg/kg).

In addition to these medications, patients will receive the standard peri-operative care at our centre, which consists of intra- operative ondansetron at the discretion of the anesthesiologist, and standing orders for acetaminophen (15 mg/kg) and ibuprofen (10 mg/kg) around the clock. Patients older than five years also receive morphine elixir (0.1 mg/kg rounded down to the nearest 0.5 mg) p.r.n (when necessary) at the discretion of the nurse. Thus, patients of all three groups will receive adequate post-operative symptom control. The Pediatric Otolaryngologist (Dr. Josee Paradis, Dr. Julie Strychowsky, or Dr. Murad Husein) who is the patient's physician and will be performing the tonsillectomy, will initially approach the participant and substitute decision maker (SDM) to describe the study. If the patient and SDM agree to consider the study, the study will be described in more detail and study consent/assent will be obtained by a research assistant or a physician (who is not the primary physician). We will recruit a convenience sample of 60 patients aged 3-13 years scheduled for tonsillectomy to be performed by the principal investigator or co-investigators (J.P., M.H. or J.S.). For children aged 3 to 6 years, SDM informed consent will be obtained; for children aged 7 to 12 years, SDM written consent and child assent will be requested; for children 13 years of age, written consent will be obtained from a SDM and from the child. The patients will be randomized to one of the three treatment groups by a computerized randomization table. Data from the tonsillectomy procedure, including whether analgesia was needed intraoperatively, and in the post-anesthesia care unit, will be recorded. Self-reported pain intensity will be scored on the Oucher tool, a number and picture scale validated in children age 3-13. A research assistant or nurse will be trained to obtain Oucher reports at the patient's bedside at specific post-operative events, which correspond to time points. The Oucher tool is simple to learn and takes minimal time to administer. The first pain report will be obtained once the patient wakes from anesthesia (15 - 45 min post- operation), then upon transfer to step-down care (1 - 2 hrs hour post-operation), then at 3 hours post-operation, and finally upon discharge (or at 5 hours post-operation, if the patient is not anticipated to be discharged by this time). Many of the details surrounding the operation will be gathered in post-hoc review of the patient's chart by the research assistant. If the patient is transferred from the PACU to the day surgery unit (i.e. discharge is anticipated before the end of the day), the information from the entire stay in the day surgery will be collected. If the patient is admitted to the floor (i.e. staying overnight in the hospital for observation), information will be collected from the first 4 hours after admission. The information gathered from the chart will include complications of surgery, whether or not the patient had post-operative bleeding requiring a change in management, and also whether or not the patient had post-operative bleeding that required an operating room procedure. Time to first oral fluid intake, as well as amount of oral intake (measured in quantity of popsicles) in the post-anesthesia care unit and total oral intake before discharge will also be gathered from the patient's chart, as well as the time to first administration of morphine, the dose of morphine required, and the frequency of post-operative vomiting until time of discharge. For home pain management, all patients are advised to take acetominophen (15mg/kg) every 6 hours as needed, alternating with ibuprofen (10mg/kg) every 6 hours as needed. At discharge (average 5 hours post-operation), parents/guardians will be provided with a package including the Pediatric Quality of Life Inventory with questions about oral intake and activity, as well as a space to record any incidents of vomiting, the Oucher tool to evaluate the patient's pain severity, and a medication log to keep track of the pain medication (over the counter or prescribed) that the patient has taken. Parents/guardians will be given a measured cup to record quantity of oral fluid intake for the day. Parents will be asked to fill out the first questionnaire at discharge (average 5 hours post-operation) time point, and they will be encouraged to raise any questions or concerns they have about how to complete the questionnaires. Subsequently, these instruments will be completed by parents/guardians (relationship to patient will be noted on each form and they will be encouraged to have the same parent/guardian complete the form each time) on post-operative days 1, 2, 3, 4, 5, 6, and 7 before bedtime. The research assistant will contact parents/guardians and patients by telephone on the first postoperative day to follow-up with any questions or concerns about the survey. On the last weekday before the patient's follow-up appointment, a reminder call will be made to ask the parent/guardian to bring their completed questionnaire to the appointment. On the 14th post-operative day patients will attend a follow-up visit where they will be assessed and their completed forms will be collected. If the patient had any emergency department visits related to the procedure, the research assistant will consult the hospital database to obtain information about the emergency department visit, including date, chief complaint, and management.

02

Conditions studied

  • Tonsillitis

Browse trials for

Keywords

  • tonsillectomy
  • acetaminophen
  • dexamethasone
03

In context

Tonsillitis

103 studies on the registry are indexed under Tonsillitis; 12 are open to participants now.

This study's planned enrollment of 60 is below the median of 100 across 87 interventional studies indexed under Tonsillitis.

Browse Tonsillitis studies →

Lead sponsor

London Health Sciences Centre is the lead sponsor of 39 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy patients
  • aged 3-13 years
  • Level I or level II on the (ASA) physical status classification system (as determined by the anesthesiologist)
  • obstructive sleep apnea or recurrent throat infections
  • undergoing elective tonsillectomy with or without adenoidectomy
  • Parents who agree to complete documentation and follow up at 14 days post-operation.

Exclusion criteria

Exclusion Criteria:

  • Patients Level III or greater on the (ASA) physical status classification system (as determined by the anesthesiologist)
  • Patients with chronic conditions that would limit our ability to develop the study according to objectives, such as neurodevelopmental conditions preventing patients from understanding the Oucher tool
  • Hepatic or renal disease
  • cardiac disease
  • active infection
  • diabetes mellitus
  • sickle cell disease
  • known coagulation disorders
  • pre- operative treatment with anti-emetics, , or analgesics
  • Acetaminophen allergy or already receiving acetaminophen within 24 h of surgery
  • Complicating health factors precluding the use of opioids or acetaminophen
  • any other factors which would interfere with pain assessment and management
  • Patients weighing more than 30 kg that would exceed maximum dexamethasone dose
  • Patients who live without a home telephone
  • patient living without parental supervision.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Phase 4
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Group 1

    Acetaminophen and High-dose dexamethasone: a single dose of oral acetaminophen (15 mg/kg) 1 hr pre-operatively and intravenous administration of high-dose dexamethasone (0.5 mg/kg, max. 10 mg) immediately after induction of anesthesia.

    Drug: Acetaminophen · Drug: High-Dose Dexamethasone

  • Active comparator
    Group 2

    Acetaminophen and Low-dose Dexamethasone: a single dose of oral acetaminophen (15 mg/kg) 1 hr pre-operatively and intravenous administration of low-dose dexamethasone (0.15 mg/kg, max. 8 mg) immediately after induction of anesthesia

    Drug: Acetaminophen · Drug: Low-dose Dexamethasone

  • Placebo comparator
    Group 3

    Placebo oral tablet and Low-dose Dexamethasone: an oral placebo given 1 hr pre-operatively and intravenous administration of low dose dexamethasone (0.15 mg/kg, max. 8 mg) immediately after induction of anesthesia.

    Drug: Low-dose Dexamethasone · Drug: Placebo Oral Tablet

Interventions

  • Oral acetaminophen (15 mg/kg) 1 hr pre-operatively

    Also known as: Tylenol

  • Intravenous low-dose dexamethasone (0.15 mg/kg, max. 8 mg) immediately after induction of anesthesia

    Also known as: Dexamethasone sodium phosphate

  • DrugPlacebo Oral Tablet

    Oral placebo 1 hr pre-operatively

    Also known as: Placebo

  • Intravenous high-dose dexamethasone (0.5 mg/kg, max. 10 mg) immediately after induction of anesthesia

    Also known as: Dexamethasone sodium phosphate

06

What researchers measure

Primary outcomes

  1. Oucher pain score

    pain intensity on the Oucher pain tool, which includes ratings by face scale and a number scale (0-10).

    Time frame: awakening from anesthesia (0.5 hours post- operation)

Secondary outcomes

  1. Analgesia use

    Whether or not intraoperative analgesia was required

    Time frame: during operation

  2. time to first oral fluid intake

    amount of time that elapses before patient has a fluid intake

    Time frame: during patient's stay in PACU (on average 5 hours)

  3. time to first request for morphine

    the time that elapses before patient requests morphine (if applicable)

    Time frame: during patient's stay in PACU (on average 5 hours)

  4. dose of morphine required

    if morphine administered, frequency, dosage and total amount of morphine patient took post-operatively

    Time frame: from end of operation to 7 days post-operation

  5. vomiting

    Number of times patient vomited after surgery

    Time frame: From end of operation to 7 days post-operation

  6. Pediatric Quality of Life Inventory

    Validated post-tonsillectomy Quality of life questionnaire with Likert-scale questions regarding common post-operative symptoms

    Time frame: Upon discharge (on average 5 hours post-operation), and 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 7 days post-operation

  7. Medication log

    Record of pain medications (over the counter and prescription) patient as taken post-discharge from hospital

    Time frame: discharge (on average 5 hours post-operation) to 7 days post-operation

  8. Oucher pain score

    pain intensity on the Oucher pain tool, which includes ratings by face scale and a number scale (0-10).

    Time frame: transfer to step-down care (1 hour post-operation), 3 hours post-operation, 5 hours post-operation, upon discharge, as well as 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 7 days post-operation

07

Study locations

1 of 1 sites recruiting
  • Children's Hospital
    London, Ontario, Canada
    Recruiting
    • Alexandria Houston · ContactAlexandria.Houston@lhsc.on.ca · 519-685-8500
    • Josee Paradis, MD · Principal investigator
    • Julie Strychowsky, MD · Sub investigator
    • Murad Husein, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2018 (actual). Primary completion is estimated for May 2021, 38 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2017
First posted
Oct 26, 2017
StartActual
Mar 1, 2018
Primary completionEst.
May 2021
CompletionEst.
Sep 2021
Last update
Feb 18, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 18, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03323047
Lead sponsor
London Health Sciences Centre
Responsible party
Dr. Josee Paradis (Paediatric Otolaryngologist Assistant Professor - Department of Otolaryngology-Head and Neck Surgery, London Health Sciences Centre) — Principal investigator
First posted
Oct 26, 2017
Start date
Mar 1, 2018
Primary completion
May 2021 (estimated)
Completion
Sep 2021 (estimated)
Last update
Feb 18, 2021

Study contacts

Josee Paradis, MD
Contact
Josee.Paradis@lhsc.on.ca
519.685.8794
Josee Paradis, MD
principal investigator · LHSC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Acetaminophen · Dexamethasone

Start the discussion